1998
DOI: 10.1016/s0923-1811(97)00067-4
|View full text |Cite
|
Sign up to set email alerts
|

Analysis of antigens targeted by circulating IgG and IgA autoantibodies in 50 patients with cicatricial pemphigoid

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

10
87
3
3

Year Published

1999
1999
2022
2022

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 95 publications
(109 citation statements)
references
References 31 publications
10
87
3
3
Order By: Relevance
“…Mucous membrane pemphigoid is a clinical phenotype that encompasses several subsets, with a wide spectrum of clinical presentation, clinical course, and prognosis. In our study, determination of patients' autoantibody profiles using commercial ELISAs allowed us to confirm that BP180 is a major autoantigen in MMP, as previously demonstrated by many studies [6][7][8][9]16,27,34,[40][41][42] performed in the past 2 decades and based on immunoblot analysis using human epidermal, amniotic membrane, or fusion proteins. These studies showed that circulating IgG autoantibodies from patients with MMP can recognize several intracellular and extracellular BP180 epitopes, sometimes distinct from the NC16A domain.…”
Section: Commentsupporting
confidence: 82%
See 2 more Smart Citations
“…Mucous membrane pemphigoid is a clinical phenotype that encompasses several subsets, with a wide spectrum of clinical presentation, clinical course, and prognosis. In our study, determination of patients' autoantibody profiles using commercial ELISAs allowed us to confirm that BP180 is a major autoantigen in MMP, as previously demonstrated by many studies [6][7][8][9]16,27,34,[40][41][42] performed in the past 2 decades and based on immunoblot analysis using human epidermal, amniotic membrane, or fusion proteins. These studies showed that circulating IgG autoantibodies from patients with MMP can recognize several intracellular and extracellular BP180 epitopes, sometimes distinct from the NC16A domain.…”
Section: Commentsupporting
confidence: 82%
“…These studies showed that circulating IgG autoantibodies from patients with MMP can recognize several intracellular and extracellular BP180 epitopes, sometimes distinct from the NC16A domain. 6,34,41,42 Using a panel of cell-derived and recombinant proteins covering the entire BP180 molecule, Schmidt et al 41 found that 19 of 26 MMP serum samples recognized BP180, including 6 (32%) that showed only IgA reactivity to this autoantigen. By immunoblotting using human epidermal, dermal, and placental amnion proteins of a large series of MMP, Oyama et al 34 similarly showed that most patients with MMP (75%) had IgG to BP180, including its soluble ectodomains.…”
Section: Commentmentioning
confidence: 99%
See 1 more Smart Citation
“…18 Second, when artificial blistering of human skin is induced by 1 mol/L NaCl, collagen XVII separates to the epidermal side of the blister and not to the dermal side with laminin 332. 33,34 Also, the Ab HK139 detected the shed Ecto-ColXVII on the epidermal side of 1 mol/L NaCl split skin, 17 suggesting that yet other epidermisassociated molecules interact with the Ecto-ColXVII. Future studies will elucidate these binding partners.…”
Section: Discussionmentioning
confidence: 99%
“…However, BP patients’ sera may also have antibodies that recognize epitopes distal to this domain, including the C-terminal domain in some patients [15, 16, 17, 18]. BP patients’ sera can also recognize distinct epitopes on the intracellular domain of BPAg2 [19].…”
Section: Discussionmentioning
confidence: 99%